Operating Lease, Right-of-Use Asset of AEON Biopharma, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: AEON Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
AEON Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,112,000, a 17% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

AEON Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$1,112,000	-$234,000	-17%	30 Sep 2025	10-Q	14 Nov 2025	2025	Q3
Q2 2025	$1,171,000	-$233,000	-17%	30 Jun 2025	10-Q	12 Aug 2025	2025	Q2
Q1 2025	$1,229,000	+$1,031,000	+521%	31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q4 2024	$1,288,000	+$1,026,000	+392%	31 Dec 2024	10-Q	14 Nov 2025	2025	Q3
Q3 2024	$1,346,000	+$1,023,000	+317%	30 Sep 2024	10-Q	13 Nov 2024	2024	Q3
Q2 2024	$1,404,000			30 Jun 2024	10-Q	12 Aug 2024	2024	Q2
Q1 2024	$198,000			31 Mar 2024	10-Q	14 May 2024	2024	Q1
Q4 2023	$262,000	-$213,000	-45%	31 Dec 2023	10-K	24 Mar 2025	2024	FY
Q3 2023	$323,000			30 Sep 2023	10-Q/A	29 Mar 2024	2023	Q3
Q4 2022	$475,000			31 Dec 2022	10-K/A	14 May 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.